Bioxytran Using Paradigm Changing Vital Sign that Can Measure Real Time Tissue Oxygen Balance in Emergency Medicine
May 20, 2019 07:05 ET
|
Bioxytran Inc.
Future use of the MDX Viewer likely to start in operating rooms, clinical trials to measure tissue balance in stroke, and to test the viability of an organ before transplantation BOSTON,...
Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
May 06, 2019 07:08 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, May 06, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company developing a pipeline of anti-necrosis drugs designed to treat...
Bioxytran Licensing FDA Approved Technology from MDX Lifesciences for use in Pipeline Drug Development
April 04, 2019 07:00 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, April 04, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by...
Bioxytran, Inc. Engages Resources Unlimited NW, LLC. for Strategic Investor Relations
March 18, 2019 07:00 ET
|
Bioxytran Inc.
BOSTON, MASSACHUSETTS, March 18, 2019 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTC: BIXT), a developmental stage biotechnology company, with a pipeline of anti-necrosis drugs designed to treat hypoxia...
Bioxytran, Inc. Pioneers First Emergency Stroke Treatment
December 17, 2018 07:00 ET
|
Bioxytran Inc.
Newly Developed Molecule Potentially Allows Oxygen Flow to the Brain BOSTON, MASSACHUSETTS, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Bioxytran Inc. (BIXT). Dr. David Platt, CEO of newly formed...
Bioxytran Inc’s New Compound for Treating Strokes Will be the Company’s New Health Mission Moving Forward
November 12, 2018 07:00 ET
|
Bioxytran Inc.
Company Formerly Known as U.S. Rare Earth Minerals, Inc. Focusing on First-In-Class Ischemic Stroke Treatment BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- U.S. Rare Earth Minerals, Inc. today...